2016 ASCO Annual Meeting - ASCO


Powered by SmugMug Log In
Dara Aisner, MD, PhD, presenting Abstract 11510, Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience

Dara Aisner, MD, PhD, presenting Abstract 11510, Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience

Chicago, IL - 2016 ASCO Annual Meeting - Precision Medicine: Dara Aisner, MD, PhD, presenting Abstract 11510, Effect of expanded genomic testing in lung adenocarcinoma (LUCA) on survival benefit: The Lung Cancer Mutation Consortium II (LCMC II) experience, during Precision Medicine: Making Progress for Patient Benefit at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Monday, June 6, 2016. Over 30,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 52nd Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Todd Buchanan 2016 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org